Raphael C. Cheung

Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study

Herbert Schuster, Philip J. Barter, Steen Stender et al. · American Heart Journal · 2004 · 161 citations

Lipid Disorder, Cardiovascular Disease, Lipid Goals +5

Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes

Louisa Pontrelli, Wendy Parris, Khosrow Adeli et al. · Metabolism · 2002 · 80 citations

Metabolic Syndrome, Cardiovascular Disease, Atorvastatin Treatment +8

Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes

V Gratl, Raphael C. Cheung, Biao Chen et al. · Atherosclerosis · 2002 · 42 citations

Inflammation, Oxysterol, Medicine +11

Treatment with atorvastatin ameliorates hepatic very[ndash ]low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: Evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity

L Mangaloglu, Raphael C. Cheung, Stephen C. Van Iderstine et al. · Metabolism · 2002 · 34 citations

Insulin Resistance, Metabolic Syndrome, Atorvastatin Ameliorates +15

Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study

Raphael C. Cheung, Jane M. Morrell, David Kallend et al. · International Journal of Cardiology · 2005 · 27 citations

Lipid Disorder, Oxysterol, Biochemistry +12